Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 23-Apr-24 4:02 PM View:  | Rangwala Reshma EVP & Chief Medical Officer | Karyopharm Therapeutics, Inc. (KPTI) | 22-Apr-24 | Sale | 6,789 | $1.17 | $7,943.13 | (2%) 349.72K to 342.93K | |
| 05-Apr-24 5:20 PM View: | Paulson Richard A. President and CEO Director | Karyopharm Therapeutics, Inc. (KPTI) | 04-Apr-24 | Sale | 3,563 | $1.29 | $4,596.27 | (< 1%) 1.16M to 1.16M | |
| 06-Mar-24 4:14 PM View: | Paulson Richard A. President and CEO Director | Karyopharm Therapeutics, Inc. (KPTI) | 05-Mar-24 | Sale | 3,573 | $1.30 | $4,644.90 | (< 1%) 1.16M to 1.16M | |
| 04-Mar-24 7:36 PM View: | Paulson Richard A. President and CEO Director | Karyopharm Therapeutics, Inc. (KPTI) | 01-Mar-24 | Sale | 19,374 | $1.20 | $23,248.80 | (2%) 1.18M to 1.16M | |
| 04-Mar-24 7:39 PM View: | Mason Michael EVP, CFO & Treasurer | Karyopharm Therapeutics, Inc. (KPTI) | 01-Mar-24 | Sale | 6,162 | $1.20 | $7,394.40 | (2%) 404.92K to 398.76K | |
| 04-Mar-24 7:41 PM View: | Rangwala Reshma EVP & Chief Medical Officer | Karyopharm Therapeutics, Inc. (KPTI) | 01-Mar-24 | Sale | 5,969 | $1.20 | $7,162.80 | (2%) 355.69K to 349.72K | |
| 04-Mar-24 7:37 PM View: | Cheng Sohanya Roshan EVP & Chief Commercial Officer | Karyopharm Therapeutics, Inc. (KPTI) | 01-Mar-24 | Sale | 5,109 | $1.20 | $6,130.80 | (1%) 398.62K to 393.51K | |
| 04-Mar-24 7:38 PM View: | Mano Michael SVP, General Counsel&Secretary | Karyopharm Therapeutics, Inc. (KPTI) | 01-Mar-24 | Sale | 3,576 | $1.20 | $4,291.20 | (1%) 281.43K to 277.85K | |
| 04-Mar-24 7:40 PM View: | Poulton Stuart EVP, Chief Development Officer | Karyopharm Therapeutics, Inc. (KPTI) | 01-Mar-24 | Sale | 6,155 | $1.20 | $7,386.00 | (2%) 335.67K to 329.51K | |
| 04-Mar-24 7:41 PM View: | Rangwala Reshma EVP & Chief Medical Officer | Karyopharm Therapeutics, Inc. (KPTI) | 29-Feb-24 | Sale | 15,667 | $1.17 | $18,330.40 | (4%) 371.36K to 355.69K | |
| 04-Mar-24 7:37 PM View: | Cheng Sohanya Roshan EVP & Chief Commercial Officer | Karyopharm Therapeutics, Inc. (KPTI) | 29-Feb-24 | Sale | 21,840 | $1.17 | $25,552.80 | (5%) 420.46K to 398.62K | |
| 04-Mar-24 7:38 PM View: | Mano Michael SVP, General Counsel&Secretary | Karyopharm Therapeutics, Inc. (KPTI) | 29-Feb-24 | Sale | 16,973 | $1.17 | $19,858.40 | (6%) 298.4K to 281.43K | |
| 04-Mar-24 7:40 PM View: | Poulton Stuart EVP, Chief Development Officer | Karyopharm Therapeutics, Inc. (KPTI) | 29-Feb-24 | Sale | 16,311 | $1.17 | $19,083.90 | (5%) 351.98K to 335.67K | |
| 04-Mar-24 7:36 PM View: | Paulson Richard A. President and CEO Director | Karyopharm Therapeutics, Inc. (KPTI) | 29-Feb-24 | Sale | 80,470 | $1.17 | $94,149.90 | (6%) 1.26M to 1.18M | |
| 04-Mar-24 7:39 PM View: | Mason Michael EVP, CFO & Treasurer | Karyopharm Therapeutics, Inc. (KPTI) | 29-Feb-24 | Sale | 27,687 | $1.17 | $32,393.80 | (6%) 432.61K to 404.92K | |
| 29-Feb-24 5:34 PM View: | Paulson Richard A. President and CEO Director | Karyopharm Therapeutics, Inc. (KPTI) | 28-Feb-24 | Grant | 442,800 | -- | -- | 54% 821.45K to 1.26M | |
| 29-Feb-24 5:36 PM View: | Rangwala Reshma EVP & Chief Medical Officer | Karyopharm Therapeutics, Inc. (KPTI) | 28-Feb-24 | Grant | 198,959 | -- | -- | 115% 172.4K to 371.36K | |
| 29-Feb-24 5:35 PM View: | Cheng Sohanya Roshan EVP & Chief Commercial Officer | Karyopharm Therapeutics, Inc. (KPTI) | 28-Feb-24 | Grant | 198,959 | -- | -- | 90% 221.5K to 420.46K | |
| 29-Feb-24 5:35 PM View: | Poulton Stuart EVP, Chief Development Officer | Karyopharm Therapeutics, Inc. (KPTI) | 28-Feb-24 | Grant | 188,205 | -- | -- | 115% 163.77K to 351.98K | |
| 29-Feb-24 5:35 PM View: | Mano Michael SVP, General Counsel&Secretary | Karyopharm Therapeutics, Inc. (KPTI) | 28-Feb-24 | Grant | 147,000 | -- | -- | 97% 151.4K to 298.4K | |
| 29-Feb-24 5:35 PM View: | Mason Michael EVP, CFO & Treasurer | Karyopharm Therapeutics, Inc. (KPTI) | 28-Feb-24 | Grant | 188,205 | -- | -- | 77% 244.4K to 432.61K | |
| 29-Feb-24 5:35 PM View: | Mason Michael EVP, CFO & Treasurer | Karyopharm Therapeutics, Inc. (KPTI) | 27-Feb-24 | Sale | 2,545 | $1.32 | $3,369.07 | (1%) 246.94K to 244.4K | |
| 20-Feb-24 4:59 PM View: | Poulton Stuart EVP, Chief Development Officer | Karyopharm Therapeutics, Inc. (KPTI) | 15-Feb-24 | Sale | 5,847 | $1.33 | $7,783.44 | (3%) 169.62K to 163.77K | |
| 08-Feb-24 4:36 PM View: | Mason Michael EVP, CFO & Treasurer | Karyopharm Therapeutics, Inc. (KPTI) | 06-Feb-24 | Sale | 4,205 | $1.59 | $6,671.23 | (2%) 251.15K to 246.94K | |
| 08-Feb-24 4:34 PM View: | Paulson Richard A. President and CEO Director | Karyopharm Therapeutics, Inc. (KPTI) | 06-Feb-24 | Sale | 4,012 | $1.59 | $6,365.04 | (< 1%) 825.47K to 821.45K | |
| 25-Jan-24 7:16 PM View: | Rangwala Reshma EVP & Chief Medical Officer | Karyopharm Therapeutics, Inc. (KPTI) | 24-Jan-24 | Grant | 14,167 | -- | -- | 9% 158.23K to 172.4K | |
| 25-Jan-24 7:40 PM View: | Cheng Sohanya Roshan EVP & Chief Commercial Officer | Karyopharm Therapeutics, Inc. (KPTI) | 24-Jan-24 | Grant | 14,167 | -- | -- | 7% 207.33K to 221.5K | |
| 25-Jan-24 7:14 PM View: | Poulton Stuart EVP, Chief Development Officer | Karyopharm Therapeutics, Inc. (KPTI) | 24-Jan-24 | Grant | 13,333 | -- | -- | 9% 156.29K to 169.62K | |
| 25-Jan-24 6:53 PM View: | Mano Michael SVP, General Counsel&Secretary | Karyopharm Therapeutics, Inc. (KPTI) | 24-Jan-24 | Grant | 9,167 | -- | -- | 6% 142.23K to 151.4K | |
| 25-Jan-24 6:47 PM View: | Mason Michael EVP, CFO & Treasurer | Karyopharm Therapeutics, Inc. (KPTI) | 24-Jan-24 | Grant | 13,333 | -- | -- | 6% 237.82K to 251.15K | |
| 25-Jan-24 6:43 PM View: | Paulson Richard A. President and CEO Director | Karyopharm Therapeutics, Inc. (KPTI) | 24-Jan-24 | Grant | 42,000 | -- | -- | 5% 783.47K to 825.47K | |
| 08-Jan-24 9:00 PM View: | Paulson Richard A. President and CEO Director | Karyopharm Therapeutics, Inc. (KPTI) | 04-Jan-24 | Sale | 4,114 | $0.82 | $3,373.48 | (< 1%) 787.58K to 783.47K | |
| 05-Dec-23 5:03 PM View: | Paulson Richard A. President and CEO Director | Karyopharm Therapeutics, Inc. (KPTI) | 04-Dec-23 | Sale | 3,622 | $0.79 | $2,861.38 | (< 1%) 791.2K to 787.58K | |
| 07-Nov-23 5:32 PM View: | Paulson Richard A. President and CEO Director | Karyopharm Therapeutics, Inc. (KPTI) | 06-Nov-23 | Sale | 3,606 | $0.92 | $3,318.60 | (< 1%) 794.81K to 791.2K | |
| 05-Oct-23 4:46 PM View: | Paulson Richard A. President and CEO Director | Karyopharm Therapeutics, Inc. (KPTI) | 04-Oct-23 | Sale | 3,589 | $1.27 | $4,558.03 | (< 1%) 798.4K to 794.81K | |
| 12-Sep-23 4:07 PM View: | Bohlin Garen G Director | Karyopharm Therapeutics, Inc. (KPTI) | 12-Sep-23 | Private Purchase | 41,140 | $1.22 | $49,985.10 | 1028% 4.0K to 45.14K | |
| 06-Sep-23 4:06 PM View: | Paulson Richard A. President and CEO Director | Karyopharm Therapeutics, Inc. (KPTI) | 05-Sep-23 | Sale | 3,622 | $1.33 | $4,816.62 | (< 1%) 802.02K to 798.4K | |
| 05-Sep-23 4:29 PM View: | Mano Michael SVP, General Counsel&Secretary | Karyopharm Therapeutics, Inc. (KPTI) | 01-Sep-23 | Sale | 3,888 | $1.33 | $5,176.09 | (3%) 146.12K to 142.23K | |
| 05-Sep-23 4:30 PM View: | Mason Michael EVP, CFO & Treasurer | Karyopharm Therapeutics, Inc. (KPTI) | 01-Sep-23 | Sale | 6,913 | $1.33 | $9,203.28 | (3%) 244.73K to 237.82K | |
| 05-Sep-23 4:27 PM View: | Cheng Sohanya Roshan EVP & Chief Commercial Officer | Karyopharm Therapeutics, Inc. (KPTI) | 01-Sep-23 | Sale | 7,415 | $1.33 | $9,871.59 | (4%) 211.5K to 204.09K | |
| 08-Aug-23 5:02 PM View: | Paulson Richard A. President and CEO Director | Karyopharm Therapeutics, Inc. (KPTI) | 07-Aug-23 | Sale | 3,722 | $1.72 | $6,401.84 | (< 1%) 805.74K to 802.02K | |
| 01-Aug-23 5:37 PM View: | Poulton Stuart EVP, Chief Development Officer | Karyopharm Therapeutics, Inc. (KPTI) | 28-Jul-23 | Sale | 2,845 | $1.70 | $4,836.50 | (2%) 159.13K to 156.29K | |
| 06-Jul-23 5:36 PM View: | Paulson Richard A. President and CEO Director | Karyopharm Therapeutics, Inc. (KPTI) | 05-Jul-23 | Sale | 3,538 | $1.72 | $6,085.36 | (< 1%) 809.28K to 805.74K | |
| 12-Jun-23 4:07 PM View: | Cheng Sohanya Roshan EVP & Chief Commercial Officer | Karyopharm Therapeutics, Inc. (KPTI) | 08-Jun-23 | Sale | 1,839 | $2.35 | $4,321.65 | (< 1%) 213.34K to 211.5K | |
| 07-Jun-23 4:11 PM View: | Paulson Richard A. President and CEO Director | Karyopharm Therapeutics, Inc. (KPTI) | 05-Jun-23 | Sale | 3,536 | $2.24 | $7,922.05 | (< 1%) 812.81K to 809.28K | |
| 05-Jun-23 4:10 PM View: | Mason Michael EVP, CFO & Treasurer | Karyopharm Therapeutics, Inc. (KPTI) | 02-Jun-23 | Sale | 631 | $2.22 | $1,400.82 | (< 1%) 245.36K to 244.73K | |
| 05-May-23 5:06 PM View: | Paulson Richard A. President and CEO Director | Karyopharm Therapeutics, Inc. (KPTI) | 04-May-23 | Sale | 3,805 | $3.35 | $12,752.80 | (< 1%) 816.62K to 812.81K | |
| 24-Apr-23 6:09 PM View: | Rangwala Reshma EVP & Chief Medical Officer | Karyopharm Therapeutics, Inc. (KPTI) | 20-Apr-23 | Sale | 6,770 | $4.05 | $27,415.80 | (4%) 165.0K to 158.23K | |
| 05-Apr-23 5:06 PM View: | Paulson Richard A. President and CEO Director | Karyopharm Therapeutics, Inc. (KPTI) | 04-Apr-23 | Sale | 3,497 | $3.97 | $13,883.10 | (< 1%) 820.12K to 816.62K | |
| 07-Mar-23 4:06 PM View: | Paulson Richard A. President and CEO Director | Karyopharm Therapeutics, Inc. (KPTI) | 06-Mar-23 | Sale | 3,506 | $3.16 | $11,079.00 | (< 1%) 823.62K to 820.12K |
